C-BREEZE 1: Efficacy and Safety of Ruzasvir 60 mg Plus Uprifosbuvir 450 mg for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) Genotype (GT)1, 2, 3, 4, or 6 InfectionEric Lawitz,Fred Poordad, Leah Anderson,Michelle Vesay,Hong Liu, Doreen Fernsler,Ernest Asante-Appiah,George J. Hanna,Michael Robertson,Eliav Barr,Joan R. Butterton,Kris V. Kowdley,Tarek I. Hassanein,Amandeep K. Sahota,Stuart C. Gordon,Wendy W. YehHEPATOLOGY（2017）引用 0|浏览11暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
